FluoGuide A/S (STO:FLUO)
Sweden · Delayed Price · Currency is SEK 40.20
+2.00 (5.24%)
Apr 14, 2026, 5:23 PM CET
FluoGuide Market Cap
FluoGuide has a market cap or net worth of 624.54 million as of April 14, 2026. Its market cap has increased by 20.99% in one year.
Market Cap
624.54M
Enterprise Value
551.35M
Revenue
318.79K
Ranking
n/a
PE Ratio
n/a
Stock Price
40.20
Market Cap Chart
Since May 13, 2019, FluoGuide's market cap has increased from 40.02M to 624.54M, an increase of 1,460.48%. That is a compound annual growth rate of 48.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 624.54M | 11.37% |
| Dec 30, 2025 | 560.78M | 5.17% |
| Dec 30, 2024 | 533.23M | -28.57% |
| Dec 29, 2023 | 746.52M | 68.50% |
| Dec 30, 2022 | 443.04M | -54.38% |
| Dec 30, 2021 | 971.21M | 4.81% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| May 13, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genovis AB (publ.) | 1.31B |
| Xspray Pharma AB | 1.26B |
| SynAct Pharma AB | 1.00B |
| Cantargia AB | 974.56M |
| Infant Bacterial Therapeutics AB | 670.20M |
| Oncopeptides AB | 534.43M |
| Corline Biomedical AB | 411.10M |
| Sprint Bioscience AB | 386.19M |